The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Trends in Tramadol: Pharmacology, Metabolism, and Misuse
Abstract
Tramadol is a unique analgesic medication, available in variety of formulations, with both monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly prescribed worldwide as an alternative for high-affinity opioid medication in the treatment of acute and chronic pain. It is a prodrug that is metabolized by cytochrome P450 (CYP) enzymes CYP2D6 and CYP3A4 to its more potent opioid analgesic metabolites, particularly the O-demethylation product M1. The opioid analgesic potency of a given dose of tramadol is influenced by an individual’s CYP genetics, with poor metabolizers experiencing little conversion to the active M1 opioid metabolite and individuals with a high metabolic profile, or ultra-metabolizers, experiencing the greatest opioid analgesic effects. The importance of the CYP metabolism has led to the adoption of computer clinical decision support with pharmacogenomics tools guiding tramadol treatment in major medical centers. Tramadol’s simultaneous opioid agonist action and serotonin (5-HT) and norepinephrine reuptake inhibitory effects result in a unique side effect profile and important drug interactions that must be considered. Abrupt cessation of tramadol increases the risk for both opioid and serotonin–norepinephrine reuptake inhibitor withdrawal syndromes. This review provides updated important information on the pharmacology, pharmacokinetics, CYP genetic polymorphisms, drug interactions, toxicity, withdrawal, and illicit use of tramadol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Clinical Pharmacology of Tramadol
Grond, S., & Sablotzki, A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00004 · Cited by 1,282
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Ingelman-Sundberg, M. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,108
Mowry, J. B., Spyker, D. A., Brooks, D. E., McMillan, N., & Schauben, J. L. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1102927 · Cited by 507
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
Raffa, R. B., Friderichs, E., Reimann, W., Shank, R. P., Codd, E. E., Vaught, J. L., Jacoby, H. I., & Selve, N. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39454-1 · Cited by 442
Kirchheiner, J., Schmidt, H., Tzvetkov, M., Keulen, J.-T., Lötsch, J., Roots, I., & Brockmöller, J. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500406 · Cited by 439
Bernard, S., Neville, K. A., Nguyen, A. T., & Flockhart, D. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-126 · Cited by 277
Chaparro, L. E., Furlan, A. D., Deshpande, A., Mailis-Gagnon, A., Atlas, S., & Turk, D. C. (2014) · Spine · doi:10.1097/brs.0000000000000249 · Cited by 273
Cited by
Roussin, A., Soeiro, T., Fouque, C., Jouanjus, E., Frauger, E., Fouilhé, N., Mallaret, M., Micallef, J., Lapeyre‐Mestre, M., & the French Addictovigilance Network (FAN) (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15323 · Cited by 38
A retrospective study of poisoning deaths from forensic autopsy cases in northeast China (Liaoning)
Wang, L.-L., Zhang, M., Zhang, W., Li, B.-X., Li, R.-B., Zhu, B.-L., Wu, X., Guan, D.-W., Zhang, G.-H., & Zhao, R. (2019) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2019.02.008 · Cited by 23
Metadata
- Authors
- Miotto, K., Cho, A. K., Khalil, M. A., Blanco, K., Sasaki, J. D., & Rawson, R.
- Venue
- Anesthesia & Analgesia
- Published
- 2017-01
- Volume
- 124
- Issue
- 1
- Pages
- 44-51
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2554311649
- Cited by
- 354
- References
- 44
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in Tramadol: Pharmacology, Metabolism, and Misuse. https://app.cochat.ai/papers/10.1213/ane.0000000000001683
- The paper
- Miotto, K., Cho, A. K., Khalil, M. A., Blanco, K., Sasaki, J. D., & Rawson, R. (2017). Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000001683
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.